Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Axsome Therapeutics, Inc. AXSM

Full chart Compare
Set alert

Price alert · AXSM

All alert types
137.00 USD -2.61 (-1.87%)

At closeNov 4, 2026, 4:00 PM EST

137.00 0.00 0.00%

After hours · Nov 4, 4:00 PM ET

134.38 Day range 140.56
123.00 52-week range 260.19
YTD
-24.99%
1 year
+1.53%

Financial health

Altman Z-Score

4.32 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -49.6×
FY 2016: -4.8×FY 2017: -4.4×FY 2018: -2.5×FY 2019: -50.4×FY 2020: -28.8×FY 2021: -10.9×FY 2022: -16.8×FY 2023: -15.1×FY 2024: -14.1×FY 2025: -49.6×
FY 2016 5y median -15.1× FY 2025
P/S 14.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 62.7×FY 2023: 13.4×FY 2024: 10.5×FY 2025: 14.2×
FY 2016 5y median 13.4× FY 2025
P/B 103×
FY 2016: 6.0×FY 2017: 7.6×FY 2018: 80.8×FY 2019: 19.7×FY 2020: 26.6×FY 2021: 90.9×FY 2022: 28.6×FY 2023: 18.9×FY 2024: 71.1×FY 2025: 103×
FY 2016 5y median 71.1× FY 2025
P/FCF -96.8×
FY 2016: -6.0×FY 2017: -4.8×FY 2018: -2.5×FY 2019: -75.8×FY 2020: -38.6×FY 2021: -13.1×FY 2022: -26.8×FY 2023: -24.8×FY 2024: -31.5×FY 2025: -96.8×
FY 2016 5y median -26.8× FY 2025
EV/EBITDA -53.6×
FY 2016: -3.7×FY 2017: -3.7×FY 2018: -2.1×FY 2019: -49.3×FY 2020: -28.9×FY 2021: -11.1×FY 2022: -17.3×FY 2023: -15.2×FY 2024: -14.4×FY 2025: -53.6×
FY 2016 5y median -15.2× FY 2025
EV/Sales 14.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 60.5×FY 2023: 12.6×FY 2024: 10.2×FY 2025: 14.1×
FY 2016 5y median 12.6× FY 2025
FCF Yield -1.0%
FY 2016: -16.5%FY 2017: -20.8%FY 2018: -39.7%FY 2019: -1.3%FY 2020: -2.6%FY 2021: -7.6%FY 2022: -3.7%FY 2023: -4.0%FY 2024: -3.2%FY 2025: -1.0%
FY 2016 5y median -3.7% FY 2025

Profitability

Gross Margin 92.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 89.6%FY 2023: 90.4%FY 2024: 91.4%FY 2025: 92.6%
FY 2016 5y median 90.4% FY 2025
Operating Margin -26.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -359.3%FY 2023: -85.7%FY 2024: -72.7%FY 2025: -26.5%
FY 2016 5y median -72.7% FY 2025
Net Margin -28.7%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -374.0%FY 2023: -88.4%FY 2024: -74.5%FY 2025: -28.7%
FY 2016 5y median -74.5% FY 2025
ROE -207.5%
FY 2016: -126.1%FY 2017: -173.1%FY 2018: -3301.5%FY 2019: -38.2%FY 2020: -90.4%FY 2021: -834.3%FY 2022: -170.8%FY 2023: -125.3%FY 2024: -503.8%FY 2025: -207.5%
FY 2016 5y median -207.5% FY 2025
ROIC -44.0%
FY 2016: -88.0%FY 2017: -101.9%FY 2018: -418.5%FY 2019: -33.8%FY 2020: -60.5%FY 2021: -190.9%FY 2022: -76.4%FY 2023: -51.4%FY 2024: -82.1%FY 2025: -44.0%
FY 2016 5y median -76.4% FY 2025
ROA -26.6%
FY 2016: -71.2%FY 2017: -81.4%FY 2018: -201.3%FY 2019: -31.0%FY 2020: -55.3%FY 2021: -148.5%FY 2022: -56.5%FY 2023: -40.7%FY 2024: -50.5%FY 2025: -26.6%
FY 2016 5y median -50.5% FY 2025

Growth (YoY)

Revenue 65.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 440.8%FY 2024: 42.5%FY 2025: 65.5%
FY 2016 FY 2025
Operating Income 39.7%
FY 2016: -199.5%FY 2017: 1.4%FY 2018: -20.9%FY 2019: -104.7%FY 2020: -47.4%FY 2021: -25.8%FY 2022: -44.2%FY 2023: -28.9%FY 2024: -21.0%FY 2025: 39.7%
FY 2016 FY 2025
EPS (diluted) 38.6%
FY 2016: -61.4%FY 2017: 10.6%FY 2018: 9.4%FY 2019: -78.3%FY 2020: -38.0%FY 2021: -22.6%FY 2022: -32.6%FY 2023: -14.6%FY 2024: -13.7%FY 2025: 38.6%
FY 2016 FY 2025
Free Cash Flow 27.0%
FY 2016: -186.7%FY 2017: -23.8%FY 2018: -13.6%FY 2019: -54.2%FY 2020: -69.2%FY 2021: -38.3%FY 2022: -8.0%FY 2023: -24.3%FY 2024: 11.7%FY 2025: 27.0%
FY 2016 FY 2025

Financial Health

Current Ratio 1.6×
FY 2016: 5.3×FY 2017: 2.9×FY 2018: 1.4×FY 2019: 9.0×FY 2020: 7.9×FY 2021: 3.8×FY 2022: 2.5×FY 2023: 3.6×FY 2024: 2.1×FY 2025: 1.6×
FY 2016 5y median 2.5× FY 2025
Quick Ratio 1.5×
FY 2016: 5.3×FY 2017: 2.9×FY 2018: 1.4×FY 2019: 9.0×FY 2020: 7.9×FY 2021: 3.8×FY 2022: 2.5×FY 2023: 3.5×FY 2024: 2.0×FY 2025: 1.5×
FY 2016 5y median 2.5× FY 2025
Debt / Equity 2.7×
FY 2016: 0.5×FY 2017: 0.6×FY 2018: 7.4×FY 2019: 0.1×FY 2020: 0.4×FY 2021: 3.2×FY 2022: 0.9×FY 2023: 1.0×FY 2024: 3.4×FY 2025: 2.7×
FY 2016 5y median 2.7× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: 1.0×FY 2017: 0.9×FY 2018: 0.2×FY 2019: 3.0×FY 2020: 1.3×FY 2021: 0.3×FY 2022: 0.6×FY 2023: 0.9×FY 2024: 0.4×FY 2025: 0.5×
FY 2016 5y median 0.5× FY 2025
Interest Coverage -25.8×
FY 2016: -208×FY 2017: -20.3×FY 2018: -29.1×FY 2019: -54.3×FY 2020: -38.6×FY 2021: -21.9×FY 2022: -24.5×FY 2023: -35.9×FY 2024: -42.7×FY 2025: -25.8×
FY 2016 5y median -25.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31